1%. Based on the analysis of structure-activity relationships(SAR) of Pamicogrel analogues, six target compounds were designed and prepared, five of them were new compounds.
在对帕米格雷类似物构效关系分析的基础上，设计并合成了六个目标化合物，其中有五个为未见文献报道的新化合物。
参考来源 - 抗血小板药帕及格雷及其衍生物的合成研究·2,447,543篇论文数据，部分数据来源于NoteExpress
The structures of Pamicogrel and its derivatives were confirmed by H-NMR, IR, MS.
帕米格雷及其衍生物的结构经过核磁共振氢谱、红外光谱、质谱等确证。
Based on the analysis of structure-activity relationships (SAR) of Pamicogrel analogues, six target compounds were designed and prepared, five of them were new compounds.
在对帕米格雷类似物构效关系分析的基础上，设计并合成了六个目标化合物，其中有五个为未见文献报道的新化合物。
The development of anti-platelet agents was described in this paper. Pamicogrel, a new anti-platelet drug, was introduced in detail, including its pharmacokinetics and pharmacodynamics.
本文介绍了抗血小板聚集药物的研究概况，并对抗血小板药物帕米格雷的药代动力学和药效学特征作了简要综述。
应用推荐